Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 850 of 1048 entries
View as:

Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)

Phase: N/A Priority: Normal
NCT ID: NCT05897268 Org: User:
Start: 06/20/23 End: 12/30/25 Due: 12/30/26

Megestrol Acetate Plus Rosuvastatin in Young Women with Early Endometrial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04491643 Org: User:
Start: 09/01/20 End: 04/11/25 Due: 04/11/26

The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02395640 Org: User:
Start: 03/31/15 End: 02/23/21 Due: 02/23/22

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06018896 Org: User:
Start: 08/25/23 End: 08/15/26 Due: 08/15/27

Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT03823079 Org: User:
Start: 02/01/19 End: 02/01/20 Due: 02/01/21

Effects of Time-Restricted Fasting on the Postprandial Glycemic Responses

Phase: N/A Priority: Normal
NCT ID: NCT05913635 Org: User:
Start: 09/01/22 End: 12/31/23 Due: 12/31/24

Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03856372 Org: User:
Start: 09/01/18 End: 10/30/28 Due: 10/30/29

HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICC

Phase: N/A Priority: Normal
NCT ID: NCT06335927 Org: User:
Start: 05/11/23 End: 05/10/26 Due: 05/10/27

The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast Lessions

Phase: N/A Priority: Normal
NCT ID: NCT05892380 Org: User:
Start: 07/01/23 End: 08/01/25 Due: 08/01/26

Bicalutamide as A Treatment in AR-positive Metastatic Triple-Negative Breast Cancer (mTNBC) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02348281 Org: User:
Start: 01/31/15 End: 12/31/15 Due: 12/31/16

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Phase: N/A Priority: Normal
NCT ID: NCT05948072 Org: User:
Start: 07/15/23 End: 07/15/26 Due: 07/15/27

Anatomical Resection in Colorectal Liver Metastases Patients

Phase: N/A Priority: Normal
NCT ID: NCT05673564 Org: User:
Start: 06/01/12 End: 05/01/19 Due: 05/01/20

Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino

Phase: N/A Priority: Normal
NCT ID: NCT06156267 Org: User:
Start: 01/31/24 End: 03/31/27 Due: 03/31/28

Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05442632 Org: User:
Start: 07/25/22 End: 12/30/25 Due: 12/30/26

Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT02120768 Org: User:
Start: 03/31/14 End: 12/31/18 Due: 12/31/19

CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC

Phase: N/A Priority: Normal
NCT ID: NCT06652412 Org: User:
Start: 11/30/24 End: 11/30/28 Due: 11/30/29

Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05759572 Org: User:
Start: 02/01/23 End: 06/01/27 Due: 06/01/28

Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT00568815 Org: User:
Start: 04/30/07 End: 12/31/10 Due: 12/31/11

Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06928584 Org: User:
Start: 03/10/25 End: 03/10/30 Due: 03/10/31

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06341556 Org: User:
Start: 05/24/24 End: 06/30/28 Due: 06/30/29

Transanal Tube Drainage in Endoscopic Submucosal Dissection of the Colorectal Tumor

Phase: N/A Priority: Normal
NCT ID: NCT02973490 Org: User:
Start: 01/31/17 End: 12/31/21 Due: 12/31/22

L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00854425 Org: User:
Start: 06/30/08 End: 01/31/12 Due: 01/31/13

The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05032768 Org: User:
Start: 01/01/21 End: 12/31/26 Due: 12/31/27

A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01550848 Org: User:
Start: 01/31/12 End: 06/30/15 Due: 06/30/16

Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic Intervention

Phase: N/A Priority: Normal
NCT ID: NCT05635630 Org: User:
Start: 06/24/22 End: 12/24/25 Due: 12/24/26